[PDF] Top 20 Perspectiva de reglamentación laboral del trabajo sexual en Colombia

... In the Bayesian framework where the NMA is con- ducted, it is possible to incorporate external data in the form of prior distributions. In particular, the mean proportion of placebo responders from ACT-1 and ULTRA-2, as ... See full document

... of trials and systematic reviews, they have yielded mixed results [5, 7, 10, 13, 38 – ...in clinical trials, we believe the NMA approach has the potential to identify the strategy that most ... See full document

... Despite these outstanding examples of successfully performed RCTs the majority of RCTs lack sufficient power and external validity. It may reflect the desperate attempts to save a RCT that Hannink et al. found a PostHoc ... See full document

... of clinical trials, absence of allocation concealment and inadequate randomization and blinding were associated with over- estimation of the ...included clinical trials [1, ... See full document

... interim analyses are performed by independent biostatisticians using the appropriate statistical programs cre- ated by the sponsor; the relevant unblinded results obtained are presented to an independent committee ... See full document

... The network meta-analyses also provide a full set of comparisons for all treatment strategies, the findings of which are presented in Tables ...the network meta-analyses can be ... See full document

... the meta-analysis by Ferrari et ...prehensive, meta-analyses have the limitation of different data sources, well performed head-to-head comparison studies being the best scientific approach to obtain ... See full document

... Electronic databases were searched (Ovid MEDLINE In- Process & Other Non- Indexed Citations, Ovid Embase and Cochrane Library) from inception to March 2018. Web of Science was searched from 2000 to March 2018. Search ... See full document

... controlled trials including 915 patients, of which the treatment group (pembrolizumab 10 mg/kg every 3 weeks) had presented improved PFS (HR = ...two trials, a finding that reinforces the superiority of ... See full document

... Limitations of the conditional planning framework A number of factors will limit the pragmatic applicability of the conditional planning framework. For instance, it will be irrelevant to the planning of a trial to ... See full document

... hospitalization (95% CI 2 11 to 2 1.5 days) with a related 0.5-week reduction in PMA at discharge (95% CI 2 1.02 to 2 0.00). There was moderate hetero- geneity for both of these outcomes, with the same 2 clear outliers ... See full document

... of analyses of outcomes may also affect the validity of clinical trial ...of analyses and discrepancies in randomized controlled trials (RCTs) by reviewing pub- lished studies that assessed ... See full document

... (b) trials with adults who were projected to require mechanical ventilation for at least 48 hours in the ICU, and (c) trials with avail- able data on the proportion of patients with overt bleed- ing, ... See full document

... “ clinical labor ” as a novel concept and traces its emer- gence through a genealogy of tentative articulations of life, labor and value – including Marx’s value theory of labor, Chicago school economics, and ... See full document

... aforementioned clinical trials often had additional cardiovascular risks that were not treated as intensively as is currently rec- ommended in clinical ...recent trials and even in a ... See full document

... For a long time it has been known that crosslinking decreases the flexibility as well as increases the rigid- ity of many material [4]. In 2003, Wollensak, firstly, reported twenty-three eyes of 22 patients with moder- ... See full document

... atric clinical research design, conduct, and ...pediatric trials and the optimal age-subgroup analyses to be performed to gain in- sight on the ef fi cacy of diverse inter- ventions in ... See full document

... The second technology tested was PRT using amustaline (S-303). This approach to target nucleic acid–containing patho- gens does not require photochemical activation through the use of a small molecule (amustaline, S-303) ... See full document

... also express a desire to avoid LABAs since the US Food and Drug Administration has advised that labeling be produced to outline the “small but significant risk in asthma related deaths” associated with their regular use. ... See full document

... KT and EJM have consulted to Merck Sharp and Dohme, Inc, Pfizer Ltd, Novartis, or Takeda on MTC issues. KT and EJM have received grant funding from the Canadian Institutes of Health Research (CIHR) Drug Safety and ... See full document